Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
59,769,952
-
Share change
-
+4,380,095
-
Total reported value
-
$2,620,044,913
-
Put/Call ratio
-
253%
-
Price per share
-
$43.97
-
Number of holders
-
158
-
Value change
-
+$194,106,946
-
Number of buys
-
91
-
Number of sells
-
47
Institutional Holders of JUNO THERAPEUTICS INC - COM (JUNO) as of Q4 2015
As of 31 Dec 2015,
JUNO THERAPEUTICS INC - COM (JUNO) was held by
158 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,769,952 shares.
The largest 10 holders included
Crestline Management, LP, FMR LLC, VANGUARD GROUP INC, Capital World Investors, FIRST TRUST ADVISORS LP, Biomark Capital Management Co. LLC, BlackRock Fund Advisors, BB BIOTECH AG, Omega Fund Management, LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
158
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.